BTK and mantle cell lymphoma: MCL cell lines treated with CG-806 exhibited a decrease in phosphorylation of the proximal BCR-associated kinases SYK and BTK, which was sustained for 24 h and was more pronounced compared to ibrutinib (Fig. 1C, D and Supplementary Fig. 2).